Toward precision nanomedicine via artificial intelligence guided design and prediction
Advanced Drug Delivery Reviews · 2026-11 · 115999
DOI: 10.1016/j.addr.2026.115999 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-11. Verfasst von Jaehyun Choi und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea. Die Arbeit nennt 78 Literaturangaben.
Abstract (Originalsprache)
Artificial intelligence (AI) is advancing nanomedicine development by linking formulation variables and biological context with delivery, therapeutic efficacy, and safety. This review examines AI assisted formulation design, centralized formulation databases, prediction of nanoparticle self assembly, and models of cell and tissue selective delivery, biodistribution, and therapeutic outcomes. Recent advances in predicting nanotoxicity and nanoparticle induced immune responses further emphasize the importance of incorporating safety endpoints into nanomedicine optimization. Beyond nanocarrier engineering, foundation models and multimodal analyses of single-cell and spatial data are expanding biological discovery by characterizing disease associated cellular states, prioritizing therapeutic targets, and predicting treatment responses. Computational approaches also support the design of therapeutic RNA, peptides, proteins, and programmable protein nanomaterials. For example, mRNA sequences generated by GEMORNA and delivered via lipid nanoparticles increased erythropoietin expression in mice by up to 15-fold compared with a benchmark sequence. Integration of biological discovery with biomolecular and nanocarrier design may inform therapeutic cargo selection, targeting strategies, and functional nanomaterial development. AI may connect patient specific biological characteristics with predictions of nanomedicine delivery and therapeutic response to support patient stratification and individualized treatment selection. Integration of histological, imaging, molecular, and longitudinal data may enable treatment strategies to be adapted to differences in tissue characteristics, disease state, and therapeutic response. Emerging approaches based on digital twins and adaptive treatment control may extend the framework toward individualized dosing and dynamic treatment optimization. Major challenges include data heterogeneity, limited model generalizability, and the need for experimental and prospective validation. Progress toward precision therapy will require integrated frameworks that jointly consider delivery, efficacy, selectivity, and safety while clearly distinguishing demonstrated applications from future opportunities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.
- College of Pharmacy, Korea University, Sejong 30019, Republic of Korea.
- Research Group in Pharmaceutical and Biomedical Sciences, Faculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 72912, Viet Nam.
- College of Pharmacy, Korea University, Sejong 30019, Republic of Korea. Electronic address: ljw1112@korea.ac.kr.
- College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea. Electronic address: ohyk@snu.ac.kr.
Zitieren
APA
Choi, J., Xu, E., Park, S., Woo, M., Le, Q. V., Lee, J., & Oh, Y. K. (2026). Toward precision nanomedicine via artificial intelligence guided design and prediction. Advanced Drug Delivery Reviews, 115999. https://doi.org/10.1016/j.addr.2026.115999
Vancouver
Choi J, Xu E, Park S, Woo M, Le QV, Lee J, et al. Toward precision nanomedicine via artificial intelligence guided design and prediction. Advanced Drug Delivery Reviews. 2026:115999. doi:10.1016/j.addr.2026.115999
BibTeX
@article{Choi2026,
author = {Choi, Jaehyun and Xu, Enzhen and Park, Sihyun and Woo, Minji and Le, Quoc-Viet and Lee, Jaiwoo and Oh, Yu-Kyoung},
title = {Toward precision nanomedicine via artificial intelligence guided design and prediction},
journal = {Advanced Drug Delivery Reviews},
year = {2026},
pages = {115999},
doi = {10.1016/j.addr.2026.115999}
}
EUVIMED